Clinical Drug Experience Knowledgebase

aldesleukin (proleukin) (3 trials)

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (3 trials)

autologous hematopoietic cell (1 trial)

bone marrow derived mesenchymal stem cells (1 trial)

busulfan (myleran) (4 trials)

carboplatin (paraplatin) (2 trials)

cisplatin (platinol) (1 trial)

cyclophosphamide (cytoxan) (2 trials)

cyclosporine (sandimmune) (2 trials)

dactinomycin (cosmegen) (1 trial)

dinutuximab (unituxin) (5 trials)

doxorubicin (Doxil) (2 trials)

etoposide (vepesid) (7 trials)

fludarabine (fludara) (4 trials)

ifosfamide (ifex) (1 trial)

isotretinoin (accutane) (2 trials)

melphalan (alkeran) (4 trials)

muromonab cd3 (Orthoclone OKT3) (2 trials)

mycophenolate (myfortic) (1 trial)

peripheral blood hematopoietic cell (1 trial)

sargramostim (leukine) (2 trials)

stem cells (1 trial)

thiotepa (4 trials)

tresulfan (3 trials)

urea (1 trial)

vincristine (oncovin) (3 trials)

adenovirus-specific t-cells (1 trial)

blinatumomab (blincyto) (1 trial)

bortezomib (velcade) (1 trial)

cytomegalovirus-specific t-cells (1 trial)

temozolomide (temodar) (1 trial)

topotecan (hycamtin) (1 trial)